Electrospray[+] Tandem Quadrupole Mass Spectrometry in The
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Nematotoxicity of Neotyphodium Infected Tall Fescue Alkaloids and Other Secondary Metabolites on Pratylenchus Scribneri
NEMATOTOXICITY OF NEOTYPHODIUM-INFECTED TALL FESCUE ALKALOIDS AND OTHER SECONDARY METABOLITES ON THE PLANT- PARASITIC NEMATODE PRATYLENCHUS SCRIBNERI by ADA ANTONIA BACETTY (Under the direction of Charles W. Bacon) ABSTRACT Tall fescue (Festuca arundinacea) is a perennial, cool-season turf and forage grass species in the United States that covers over 20 million hectares of pastureland. Neotyphodium coenophialum, an endophytic fungus associated with cool-season grasses, enhances host fitness and imparts pest resistance to the grass. Biologically active alkaloids and other secondary metabolites are produced in this association that not only cause adverse effects on livestock, fescue toxicosis, but may also play a role in the reduction of plant-parasitic nematode populations. Currently there is little information available on the effects of these biologically active compounds on nematodes associated with tall fescue. Therefore, this research examines the interaction of ergot and loline alkaloids, as well as polyphenolic compounds, from endophyte-infected tall fescue on toxicity to the lesion nematode, Pratylenchus scribneri. In vitro bioassays were performed to assess the effects of specifically identified compounds on P. scribneri motility, mortality, and chemoreception. While separate greenhouse studies evaluated the effects of endophyte- infected tall fescue on P. scribneri viability. Root extracts served as nematistatic agents to the nematodes in the chemical submersion assays and affected nematode behavior by acting as repellents in chemoreception studies. During individual tests, ergovaline and α-ergocryptine were nematicidal at 5µg/ml and 50µg/ml respectively. However, chemotaxis studies revealed α-ergocryptine as an attractant (1-20µg/ml) and repellent (50-200µg/ml). Ergovaline was an effective repellent (1-5µg/ml) and a nematicidal (10-200µg/ml). -
Occurrence and Significance of Mycotoxins in Forage Crops And
J Sci Food Agric 1998, 77,1È17 Occurrence and Signiücance of Mycotoxins in Forage Crops and Silage: a Review Keith A Scudamore1* and Christopher T Livesey2 1 Central Science Laboratory, London Road, Slough, Berks, SL3 7HJ, UK 2 Veterinary Laboratories Agency, New Haw, Woodham Lane, Addlestone, Surrey, KT15 3NB, UK (Received 5 December 1996; revised version received 29 May 1997; accepted 4 September 1997) Abstract: Study of mycotoxins in animal feeding stu†s has concentrated on the occurrence of aÑatoxins and, to a lesser extent, other mycotoxins in cereals, raw materials and concentrate feeds. However, ruminant diets contain a high propor- tion of forage crops such as grass or maize silage, hay and straw. Under adverse growing, production or storage conditions, fungal spoilage is likely to occur with some degree of mycotoxin contamination. The mould Ñora of forage crops is likely to di†er signiÐcantly from that of cereals and mycotoxin contamination, should it occur, could di†er qualitatively and quantitatively. Information relating to forage crops as a potential source of mycotoxins is reviewed. Some Ðeld inci- dents and animal disease which may be mycotoxin related are discussed and analytical methods are reviewed. Information on dose and e†ect of candidate mycotoxins is given where available. The review suggests areas which the authors consider merit further study. Crown Copyright 1998. J Sci Food Agric 77,1È17 (1998) Key words: mycotoxins; fungi; moulds; silage; forage crops; hay; straw; occurrence; analysis; risk assessment; animal disease INTRODUCTION access, silage will be at risk from storage moulds such as Penicillium and Aspergillus. However, moulds may be During growth, forage crops are at risk in the Ðeld from aerobic or anaerobic and this means that, even if infection by a number of di†erent fungi, some of which oxygen is excluded, some moulds may be able to may produce mycotoxins. -
Risk Assessment of Argyreia Nervosa
Risk assessment of Argyreia nervosa RIVM letter report 2019-0210 W. Chen | L. de Wit-Bos Risk assessment of Argyreia nervosa RIVM letter report 2019-0210 W. Chen | L. de Wit-Bos RIVM letter report 2019-0210 Colophon © RIVM 2020 Parts of this publication may be reproduced, provided acknowledgement is given to the: National Institute for Public Health and the Environment, and the title and year of publication are cited. DOI 10.21945/RIVM-2019-0210 W. Chen (author), RIVM L. de Wit-Bos (author), RIVM Contact: Lianne de Wit Department of Food Safety (VVH) [email protected] This investigation was performed by order of NVWA, within the framework of 9.4.46 Published by: National Institute for Public Health and the Environment, RIVM P.O. Box1 | 3720 BA Bilthoven The Netherlands www.rivm.nl/en Page 2 of 42 RIVM letter report 2019-0210 Synopsis Risk assessment of Argyreia nervosa In the Netherlands, seeds from the plant Hawaiian Baby Woodrose (Argyreia nervosa) are being sold as a so-called ‘legal high’ in smart shops and by internet retailers. The use of these seeds is unsafe. They can cause hallucinogenic effects, nausea, vomiting, elevated heart rate, elevated blood pressure, (severe) fatigue and lethargy. These health effects can occur even when the seeds are consumed at the recommended dose. This is the conclusion of a risk assessment performed by RIVM. Hawaiian Baby Woodrose seeds are sold as raw seeds or in capsules. The raw seeds can be eaten as such, or after being crushed and dissolved in liquid (generally hot water). -
United States Patent (19) [11] 3,968,111 Bach Et Al
United States Patent (19) [11] 3,968,111 Bach et al. (45) July 6, 1976 54 8,8-DISUBSTITUTED-6- 3,113,133 12/1963 Hofmann et al..w. 260/285.5 METHYLERGOLINES AND RELATED COMPOUNDS Primary Examiner-Alton D. Rollins 75) inventors: Nicholas J. Bach; Edmund C. Assistant Examiner-Mary Vaughn Kornfeld, both of Indianapolis, Ind. Attorney, Agent, or Firm-James L. Rowe, Everet F. 73) Assignee: Eli Lilly and Company, Indianapolis, Smith Ind. 22 Filed: Dec. 6, 1974 21 Appl. No.: 530,320 57 ABSTRACT 8,8-Disubstituted-6-methylergolines and 9-ergolenes, 52 U.S. Cl............................... 260/285.5; 424/261 prepared by alkylation of lysergic, isolysergic or their 51 int. C.’................ C07D 457/02; C07D 457/10 9,10-dihydro analogues, optionally followed by chemi 58) Field of Search.................................. 260/285.5 cal modification of an 8-substituent. 56 References Cited UNITED STATES PATENTS 9 Claims, No Drawings 2,86,074 1 1/1958 Kornfeld et al.................. 260/285.5 3,968, 111 1 2 1722 (1957) prepared the 8-methyl derivative of D-iso 8,8-DISUBSTITUTED-6-METHYLERGOLINES AND lysergic acid diethylamide, stating that they were, how RELATED COMPOUNDS ever, unable to obtain substitution at C8 using dihydro lysergic acid methyl ester and the alkylating agent used BACKGROUND OF THE INVENTION successfully with lysergic acid itself; to wit, methylio Compounds based on the ergoline ring system dide and potassium amide. These authors also prepared 8-ethyl-D-isolysergic acid diethylamide and the 1,8- dimethyl-D-isolysergic acid diethylamide. There is no mention in the literature of an 8,8-disubstituted-9-ergo O lene in which the substituents at 8 are other than amide groups and in which the 1-position is not substituted. -
UNIVERSITY of CALIFORNIA Los Angeles Synthesis Of
UNIVERSITY OF CALIFORNIA Los Angeles Synthesis of Functionalized α,α-Dibromo Esters through Claisen Rearrangements of Dibromoketene Acetals and the Investigation of the Phosphine-Catalyzed [4 + 2] Annulation of Imines and Allenoates A dissertation submitted in partial satisfaction of the requirements for the degree Doctor of Philosophy in Chemistry by Nathan John Dupper 2017 ABSTRACT OF THE DISSERTATION Synthesis of Functionalized α,α-Dibromo Esters through Claisen Rearrangements of Dibromoketene Acetals and the Investigation of the Phosphine-Catalyzed [4 + 2] Annulation of Imines and Allenoates by Nathan John Dupper Doctor of Philosophy in Chemistry Univsersity of California, Los Angeles, 2017 Professor Ohyun Kwon, Chair Allylic alcohols can be transformed into γ,δ-unsaturated α,α-dibromo esters through a two- step process: formation of a bromal-derived mixed acetal, followed by tandem dehydrobromination/Claisen rearrangement. The scope and chemoselectivity of this tandem process is broad and it tolerates many functional groups and classes of allylic alcohol starting material. The diastereoselectivity of the Claisen rearrangement was investigated with moderate to excellent diastereomeric selectivity for the formation of the γ,δ-unsaturated α,α-dibromo esters. The product α,α-dibromo esters are also shown to be valuable chemical building blocks. They were used in the synthesis of the ynolate reaction intermediate, as well as other carbon–carbon bond- forming reactions. Highly functionalized lactones were also shown to be simply prepared from the γ,δ-unsaturated α,α-dibromo ester starting materials formed via the Cliasen rearrangement. ii A phosphine-catalyzed [4 + 2] annulation of imines and allenoates is also investigated herein. -
Phoretic Analysis of Ergot Alkaloids. Relations Mobility in the Cle Vine
Acta Pharm, Suecica 2, 357 (1965) Thin-layer chromatographic and thin-layer electro- phoretic analysis of ergot alkaloids.Relations between structure, RM value and electrophoretic mobility in the cle vine series STIG AGUREll DepartMent of PharmacOgnosy, Kunql, Farmaceuliska Insiitutei, StockhOLM, Sweden SUMMARY A thin-layer chromatographic and electrophoretic study of the ergot alkaloids has been made, to find rapid methods for the separation and identification of the known ergot alkaloids. The mobilities of ergot alkaloids in several useful chromatographic and electrophore- tic systems are recorded. Relations have been observed between structure and R" value in methanol-chloroform on Silica Gel G. A simple, rapid thin-layer electrophoretic technique has been de- vised for separation of ergot alkaloids, and a relation between structure and electrophoretic mobility is evident. Two-dimensional combinations of thin-layer chromatography and thin-layer electro- phoresis and chromatography are described. Numerous paper chromatographic procedures have been published for separation of the ergot alkaloids and their derivatives. Hofmann (1) and Genest & Farmilio (2) have recently listed these systems. The general advantages of thin-layer chromatography (TLC) over paper partition chromatography are well known: shorter time of equilibration and devel- opment, generally better resolution, smaller amounts of substance rc- quired, and wider choice of reagents. Several reports of TLC of ergot alkaloids have been published. In gene- ral, these investigations (2-6 and others) have dealt 'with limited groups of alkaloids, or with a specific problem involving at most a dozen of the 40 now known naturally occurring ergot alkaloids. Some paper chromate- .357 graphic systems using Iorrnamide-treated papers have also been adopted for thin-layer chromatographic use (7, 8). -
Studies on Oxidation of Ergot Alkaloids: Oxidation and Desaturation of Dihydrolysergol—Stereochemical Requirements
Tetrahedron 63 (2007) 10466 10478 Studies on oxidation of ergot alkaloids: oxidation and desaturation of dihydrolysergol—stereochemical requirements Radek Gazˇak,a Vladimır Krˇen,a,* Petr Sedmera,a Daniele Passarella,b Michaela Novotnaa and Bruno Danielib aInstitute of Microbiology, Academy of Sciences of the Czech Republic, Vıdensk a 1083, CZ 14220 Prague 4, Czech Republic bDipartimento di Chimica Organica e Industriale, Universita degli Studi di Milano, Via Venezian 21, 20133 Milano, Italy Received 6 June 2007; revised 24 July 2007; accepted 26 July 2007 Available online 1 August 2007 Abstract A new method for the oxidation of ergoline alcohols to aldehydes was found (TFFA DMSO, 78 C, then DIPEA). Structural features of ergolines required for successful C7 C8 double bond introduction via Polonovski Potier reaction of respective 6 N oxides were defined and experimentally confirmed: (i) the presence of electron withdrawing group at C 8; (ii) trans diaxial orientation of N6 O and C7 H bonds (both requirements are fulfilled for dihydrolyserg 17 al and its 2,4 dinitrophenyl hydrazone prepared in this work). Ó 2007 Published by Elsevier Ltd. 1. Introduction Many therapeutically used EA belong to the peptide alka- loids, but a significant number is semisynthetically prepared Ergot alkaloids (EA) cover a broad range of therapeutic uses whose production is based on few basic precursors (Fig. 1), as the drugs of high potency in the treatment of various e.g., lysergic acid (1) and 9,10-dihydrolysergic acid (2), disorders, such as, e.g., uterine atonia, postpartum bleeding, lysergol (3), 9,10-dihydrolysergol (4) (available from the migraine, orthostatic circulatory disturbances, senile cere- seeds of some Ipomoea species2), and elymoclavine (5) pro- bral insufficiency, hypertension, hyperprolactinemia, acro- duced in good yields by the submerged cultivation of some megaly, and parkinsonism.1 Claviceps strains (e.g., C. -
3.3.11 Synthesis of Lysergic Acid Diethylamide by Vollhardt...67
Copyright by Jason Anthony Deck 2007 The Dissertation Committee for Jason Anthony Deck certifies that this is the approved version of the following dissertation: Studies Towards the Total Synthesis of Condylocarpine and Studies Towards the Enantioselective Synthesis of (+)-Methyl Lysergate Committee: Stephen F. Martin, Supervisor Philip D. Magnus Michael J. Krische Richard A. Jones Sean M. Kerwin Studies Towards the Total Synthesis of Condylocarpine and Studies Towards the Enantioselective Synthesis of (+)-Methyl Lysergate by Jason Anthony Deck, B.S.; M.S. Dissertation Presented to the Faculty of the Graduate School of The University of Texas at Austin in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy The University of Texas at Austin May 2007 Studies Towards the Total Synthesis of Condylocarpine and Studies Towards the Enantioselective Synthesis of (+)-Methyl Lysergate Publication No. _______ Jason Anthony Deck, PhD The University of Texas at Austin, 2007 Supervisor: Stephen F. Martin An iminium ion cascade sequence was designed and its implementation attempted to form the pentacyclic core structure of the natural product condylocarpine. Trapping of the transient Pictet-Spengler-type spiroindolenium ion with a latent nucleophile would form two of the five rings of condylocarpine in a regioselective manner. Progress towards the first fully stereocontrolled synthesis of a lysergic acid derivative has been described. The route utilizes intermediates with the appropriate oxidation state for the target, and the two stereocenters are installed via asymmetric catalysis. The d ring and second stereocenter were simultaneously formed via an unprecedented microwave heated asymmetric ring closing metathesis (ARCM). iv Table of Contents List of Figures..................................................................................................... -
Cover Next Page > Cover Next Page >
cover next page > Cover title: The Psychopharmacology of Herbal Medicine : Plant Drugs That Alter Mind, Brain, and Behavior author: Spinella, Marcello. publisher: MIT Press isbn10 | asin: 0262692651 print isbn13: 9780262692656 ebook isbn13: 9780585386645 language: English subject Psychotropic drugs, Herbs--Therapeutic use, Psychopharmacology, Medicinal plants--Psychological aspects. publication date: 2001 lcc: RC483.S65 2001eb ddc: 615/.788 subject: Psychotropic drugs, Herbs--Therapeutic use, Psychopharmacology, Medicinal plants--Psychological aspects. cover next page > < previous page page_i next page > Page i The Psychopharmacology of Herbal Medicine < previous page page_i next page > cover next page > Cover title: The Psychopharmacology of Herbal Medicine : Plant Drugs That Alter Mind, Brain, and Behavior author: Spinella, Marcello. publisher: MIT Press isbn10 | asin: 0262692651 print isbn13: 9780262692656 ebook isbn13: 9780585386645 language: English subject Psychotropic drugs, Herbs--Therapeutic use, Psychopharmacology, Medicinal plants--Psychological aspects. publication date: 2001 lcc: RC483.S65 2001eb ddc: 615/.788 subject: Psychotropic drugs, Herbs--Therapeutic use, Psychopharmacology, Medicinal plants--Psychological aspects. cover next page > < previous page page_ii next page > Page ii This page intentionally left blank. < previous page page_ii next page > < previous page page_iii next page > Page iii The Psychopharmacology of Herbal Medicine Plant Drugs That Alter Mind, Brain, and Behavior Marcello Spinella < previous page page_iii next page > < previous page page_iv next page > Page iv © 2001 Massachusetts Institute of Technology All rights reserved. No part of this book may be reproduced in any form by any electronic or mechanical means (including photocopying, recording, or information storage and retrieval) without permission in writing from the publisher. This book was set in Adobe Sabon in QuarkXPress by Asco Typesetters, Hong Kong and was printed and bound in the United States of America. -
Introduction to the Pharmacology of Ergot Alkaloids and Related Compounds As a Basis of Their Therapeutic Application
CHAPTER I Introduction to the Pharmacology of Ergot Alkaloids and Related Compounds as a Basis of Their Therapeutic Application B. BERDE and E. STURMER "Truth is rarely pure and never simple" OSCAR WILDE This chapter, rather unorthodox for a volume of the Handbook of Experimental Pharmacology, is not intended as a summary of the wealth of information accumu- lated in this book. It is an attempt at a compact synopsis to help those teaching pharmacology or writing a textbook of pharmacology not to overlook the essential chemical and biological basis of the therapeutically most important compounds and those of their activities which are believed to be relevant for their therapeutic effects. The present volume, entitled Ergot Alkaloids and Related Compounds, deals with chemical entities containing the tetracyclic ergolene- or ergoline-ring system. They can be obtained by extraction of different strains of the fungus cIaviceps- grown on rye or cultivated in fermentation tanks-or alternatively by partial or total synthesis. These compounds can be divided into four main structural groups: cIavine alkaloids, lysergic acids, simple lysergic acid-amides, and peptide alkaloids. One example of each type of molecule is given in Figure 1. The degree of oxidation is a criterion for further differentiation in the group of cIavine alkaloids, all of which are compounds of minor biological importance. The naturally occurring lysergic acids are divided into compounds with a double bond in the 8-9 position (8-ergolenes) and in the 9-10 position (9-ergolenes). All congeners are methylated in position (i. The two asymmetric carbon atoms in position 5 and 10 (in the case of 8-ergolenes) or 5 and 8 (in the case of Glavine-Alkaloids Lysergic Acid group Lysergic Acid Amides Peptide-Alkaloids of Alkaloids Examples: I'_ GOOH I"'" NH'GH3 b ~HN Elymoclavine D-Lysergic Acid Ergometrine Ergotamine Fig. -
Potential of Solid State Fermentation for Production of Ergot Alkaloids
c.3 /' Letters in Applied Microbiology 1992, 15, 156-159 Potential of solid state fermentation for production of ergot alkaloids M.R. TREJOHERNANDEZ, M. RAIMBAULT~,S. Roussost & B.K. LONSANE*$ Biotechnology Department, Autonomous Metropolitan University, Iztapalapa, AP 55-535, 09340 México, tBiotechnology Unit, ORSTOM Centre Montpellier, 911 Avenue Agropolis, BP 5045,34032 Montpellier Cedex I, France and $Fermentation Technology and Bioengineering Discipline, Central Food Technological Research Institute, Mysore-570 013, India FS/136: received 28 October 1991 and accepted 15 June 1992 I TREJOHERNANDEZ, M.R., RAIMBAULT,M., Roussos, S. & LONSANE,B.K. 1992. Potential of solid state fermentation for production of ergot alkaloids. Letters in Applied Microbiology 15, 156-159. I Production of total ergot alkaloids by Clauiceps fusiformis in solid state fermenta- l tion was 3.9 times higher compared to that in submerged fermentation. Production was equal in the case of Clauiceps purpurea but the spectra of alkaloids were advan- tageous with the use of solid state fermentation. The data establish potential of solid state fermentation which was not explored earlier for production of ergot alkaloids. A significant increase in demand of ergot alka- technique, which is known to simulate natural loids have been witnessed in recent years (Esser growth of micro-organisms (Lonsane et al. 1985) i & Diivell 1984). Consequently, their saprophytic but was never evaluated earlier for production .I production by submerged fermentation (SmF) I of ergot alkloids. has gained critical importance as conventional 1 parasitic production has many limitations ! Materials and Methods .I (Rehácek 1984). Considerable R and D efforts I have been put up in recent years to improve the Clauiceps purpurea 1029c was obtained from the productivity of the fermentation process. -
(12) Patent Application Publication (10) Pub. No.: US 2004/0132780 A1 Allen Et Al
US 2004O132780A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2004/0132780 A1 Allen et al. (43) Pub. Date: Jul. 8, 2004 (54) METHOD AND COMPOSITIONS FOR (52) U.S. Cl. .............................................................. 514/334 TREATING MIGRAINES (76) Inventors: Christopher P. Allen, Doylestown, PA (57) ABSTRACT (US); Phyllis W. Stone, Somerset, NJ (US); Sean Harper, Gwynedd Valley, The present invention relates to a method for treating or PA (US) preventing migraines in a mammalian patient in need of Such treatment or prevention comprising administering to Correspondence Address: Said patient a compound of Formula A or a pharmaceutically MERCKAND COINC Salt, hydrate or N-oxide thereof, in an amount that is PO BOX 2000 effective to treat or prevent migraines. RAHWAY, NJ 070650907 (21) Appl. No.: 10/476,753 (A) SOCH (22) PCT Filed: Apr. 30, 2002 (86) PCT No.: PCT/US02/13750 C N (30) Foreign Application Priority Data 4. N May 4, 2001 (US).......................................... 60/288623 2 Publication Classification (51) Int. Cl." ............................................ A61K 31/444 US 2004/O132780 A1 Jul. 8, 2004 METHOD AND COMPOSITIONS FOR TREATING DETAILED DESCRIPTION MIGRAINES 0007. The present invention encompasses a method for BACKGROUND OF THE INVENTION treating or preventing migraines in a mammalian patient in need of Such treatment or prevention comprising adminis 0001 Migraines are recurrent, often familial, symptom tering to Said patient a compound of Formula A: complexes of periodic attacks of vascular headache. The condition is characterized by intermittent attacks of head ache, preceded by an aura in approximately 15% of patients. The headache is often accompanied by associated Symp SOCH3 toms, most commonly nausea, vomiting, photophobia and phonophobia.